Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease.

Ridruejo, Ezequiel

Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease. [electronic resource] - Nefrologia - 46-52 p. digital

Publication Type: Journal Article; Multicenter Study; Observational Study

2013-2514

10.1016/j.nefro.2019.03.013 doi


2-Naphthylamine
Amides--therapeutic use
Anilides--therapeutic use
Antiviral Agents--adverse effects
Benzimidazoles--therapeutic use
Benzofurans--therapeutic use
Carbamates--therapeutic use
Cyclopropanes--therapeutic use
Drug Combinations
Drug Therapy, Combination
Female
Genotype
Hepacivirus--genetics
Hepatitis C--complications
Humans
Imidazoles--therapeutic use
Lactams, Macrocyclic--therapeutic use
Male
Middle Aged
Proline--analogs & derivatives
Pyrrolidines--therapeutic use
Quinoxalines--therapeutic use
Renal Insufficiency, Chronic--complications
Ritonavir--therapeutic use
Simeprevir--therapeutic use
Sofosbuvir--therapeutic use
Sulfonamides--therapeutic use
Sustained Virologic Response
Uracil--analogs & derivatives
Valine--analogs & derivatives